U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07478328) titled 'Chaigui Longmu Ejiao Paste for Ischemic Heart Disease' on March 08.
Brief Summary: This study explores whether Chaigui Longmu Ejiao Paste can reduce the average weekly number of angina attacks in patients with ischemic heart disease after 8 weeks of treatment, using Chaigui Longmu Paste without Ejiao as a parallel control and incorporating a synthesized external control.
Study Start Date: March 08
Study Type: INTERVENTIONAL
Condition:
Ischemic Heart Disease
Intervention:
DRUG: Standard Western medicine treatment + Chaigui Longmu Ejiao Paste
15 g orally twice daily
DRUG: Placebo Comparator: Standard Western medicine treatmen...